Beate Schmöele-Thoma

4.3k citations

54 papers · 1.8k indexed · h-index 22

Co-authors: William C. Gruber Daniel A. Scott Emilio A. Emini Alejandra Gurtman Kathrin U. Jansen Lisa A. Jackson Martin van Cleeff Deepthi Jayawardene
Topics: Pneumonia and Respiratory Infections (44 papers)Respiratory viral infections research (37 papers)Bacterial Infections and Vaccines (16 papers)
Cited by: Microbiology Epidemiology Health
Journals: New England Journal of Medicine Clinical Infectious Diseases The Journal of Infectious Diseases
Partner nations: United States Germany United Kingdom

In The Last Decade

Beate Schmöele-Thoma

46 papers receiving 1.7k citations

Peers

Countries citing papers authored by Beate Schmöele-Thoma

Since Specialization

Citations

This map shows the geographic impact of Beate Schmöele-Thoma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Schmöele-Thoma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Schmöele-Thoma more than expected).

Fields of papers citing papers by Beate Schmöele-Thoma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Schmöele-Thoma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Schmöele-Thoma. The network helps show where Beate Schmöele-Thoma may publish in the future.

Co-authorship network of co-authors of Beate Schmöele-Thoma

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Schmöele-Thoma. A scholar is included among the top collaborators of Beate Schmöele-Thoma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Schmöele-Thoma. Beate Schmöele-Thoma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South Africa 2025 ·Open Forum Infectious Diseases ·Shabir A. Madhi,Eric A. F. Simões,Nicola P. Klein,Agnieszka Zareba,Philip R. Dormitzer,Daniel A. Scott,Alejandra Gurtman,William C. Gruber,Kathrin U. Jansen,David Cooper,Bing Cai,Beate Schmöele-Thoma,Kena A. Swanson	0
2	A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization 2024 ·Vaccines ·Bing Cai,Yili Chen,(unknown),Beate Schmöele-Thoma,Kenneth Koury,Kathrin U. Jansen,William C. Gruber,Philip R. Dormitzer,Kena A. Swanson	0
3	A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6–64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines 2021 ·Vaccine ·Yoshitaka Yamazaki,Masanori Ikeda,Takayuki Imada,Kenji Furuno,Tomoyuki Mizukami,(unknown),Yasuko Shoji,(unknown),(unknown),Peter C. Giardina,Beate Schmöele-Thoma,Daniel A. Scott	2
4	Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence 2020 ·Human Vaccines & Immunotherapeutics ·(unknown),Daniel A. Scott,Beate Schmöele-Thoma,Wendy Watson,Mary M. Moran,Raúl Istúriz	8
5	Diabetes mellitus as a vaccine-effect modifier: a review 2020 ·Expert Review of Vaccines ·(unknown),Mark A. Fletcher,Jose A Suaya,Sally Jackson,(unknown),Daniel A. Scott,Beate Schmöele-Thoma,Raúl Istúriz,Bradford D. Gessner	20
6	Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults 2019 ·Human Vaccines & Immunotherapeutics ·Beate Schmöele-Thoma,Martin van Cleeff,Richard N. Greenberg,Alejandra Gurtman,Thomas R. Jones,Vani Sundaraiyer,William C. Gruber,Daniel A. Scott	6
7	Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial 2018 ·Human Vaccines & Immunotherapeutics ·Allison Thompson,Nicola P. Klein,H. Jackson Downey,Scott D. Patterson,Vani Sundaraiyer,Wendy Watson,(unknown),Kathrin U. Jansen,Shite Sebastian,William C. Gruber,Daniel A. Scott,Beate Schmöele-Thoma	16
8	Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations 2018 ·Human Vaccines & Immunotherapeutics ·Christine Juergens,James Trammel,Yasuko Shoji,Scott D. Patterson,Wendy Watson,Chris Webber,William C. Gruber,Daniel A. Scott,Beate Schmöele-Thoma	4
9	Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age 2017 ·Expert Review of Vaccines ·Raúl Istúriz,(unknown),John M. McLaughlin,Vincenza Snow,Beate Schmöele-Thoma,Chris Webber,Allison Thompson,Daniel A. Scott	12
10	Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial 2017 ·Human Vaccines & Immunotherapeutics ·(unknown),Christine Juergens,(unknown),(unknown),Vani Sundaraiyer,(unknown),Mark Cutler,William C. Gruber,Daniel A. Scott,Beate Schmöele-Thoma	12
11	Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older 2016 ·Vaccine ·Robert W. Frenck,Anne Fiquet,Alejandra Gurtman,Martin van Cleeff,Matthew Davis,John Rubino,William B. Smith,Vani Sundaraiyer,Mohinder Sidhu,Emilio A. Emini,William C. Gruber,Daniel A. Scott,Beate Schmöele-Thoma	21
12	Pneumococcal conjugate vaccine use in adults 2015 ·Expert Review of Vaccines ·Raúl Istúriz,Beate Schmöele-Thoma,Daniel A. Scott,Luis Jódar,Chris Webber,Heather L. Sings,Peter R. Paradiso	15
13	Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study 2015 ·Clinical Infectious Diseases ·Catherine Cordonnier,Per Ljungman,Christine Juergens,Johan Maertens,Dominik Selleslag,Vani Sundaraiyer,Peter C. Giardina,(unknown),William C. Gruber,Daniel A. Scott,Beate Schmöele-Thoma	69
14	Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination 2015 ·AIDS ·As’ad E. Bhorat,Shabir A. Madhi,(unknown),Vani Sundaraiyer,Alejandra Gurtman,Kathrin U. Jansen,Daniel A. Scott,Emilio A. Emini,William C. Gruber,Beate Schmöele-Thoma	43
15	Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age 2014 ·Vaccine ·Richard N. Greenberg,Alejandra Gurtman,Robert W. Frenck,Cynthia Strout,Kathrin U. Jansen,James Trammel,Daniel A. Scott,Emilio A. Emini,William C. Gruber,Beate Schmöele-Thoma	115
16	Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older 2013 ·Vaccine ·Lisa A. Jackson,Alejandra Gurtman,Martin van Cleeff,Robert W. Frenck,John Treanor,Kathrin U. Jansen,Daniel A. Scott,Emilio A. Emini,William C. Gruber,Beate Schmöele-Thoma	130
17	Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine 2013 ·Vaccine ·Lisa A. Jackson,Alejandra Gurtman,Kathryn Rice,Karlis Pauksens,Richard N. Greenberg,Thomas R. Jones,Daniel A. Scott,Emilio A. Emini,William C. Gruber,Beate Schmöele-Thoma	140
18	Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1×, 2×, or 4×) in healthy subjects aged 70 years or older 2011 ·Vaccine ·H. Lode,Beate Schmöele-Thoma,William C. Gruber,(unknown),Philip Fernsten,S. Baker,Ahmad Razmpour,George R. Siber,Jill Hackell,Stephen Lockhart,Olaf Burkhardt,Tobias Welte,A de Roux	19
19	Safety and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Given Concomitantly with Trivalent Inactivated Influenza Vaccine in Healthy Adults 2009 ·Journal of the American Geriatrics Society ·Tino F. Schwarz,(unknown),H. C. Rümke,(unknown),C. Juergens,A Wenz,Deepthi Jayawardene,Peter C. Giardina,William C. Gruber,Beate Schmöele-Thoma	0
20	Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory 2008 ·Clinical Infectious Diseases ·A de Roux,Beate Schmöele-Thoma,George R. Siber,Jill Hackell,(unknown),(unknown),(unknown),Ahmad Razmpour,Emilio A. Emini,Philip Fernsten,William C. Gruber,Stephen Lockhart,Olaf Burkhardt,Tobias Welte,H. Lode	199

About Beate Schmöele-Thoma

Beate Schmöele-Thoma is a scholar working on Microbiology, Epidemiology and Immunology, having authored 54 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (44 papers), Respiratory viral infections research (37 papers) and Bacterial Infections and Vaccines (16 papers). The work is most often cited by research in Microbiology (373 citations), Epidemiology (1.6k citations) and Health (130 citations). Beate Schmöele-Thoma has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include William C. Gruber, Daniel A. Scott, Emilio A. Emini, Alejandra Gurtman, Kathrin U. Jansen, Lisa A. Jackson, Martin van Cleeff, Deepthi Jayawardene, Robert W. Frenck and Richard N. Greenberg. Their work appears in journals such as New England Journal of Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact